Research brief: Oseltamivir is effective against H5N1

US research has indicated that oseltamivir (Tamiflu) is effective against the H5N1 avian flu virus, at least in rodents. The research presented at 'Bird Flu: the first pandemic of the 21st Century', a conference held in London last week, found that the drug had a dose-dependent prophylactic effect in healthy mice. It also produced a survival rate of up to 80 per cent in infected mice and significantly reduced levels of the virus in the lungs. Similar trials in ferrets showed oseltamivir prevented virus replication in the upper respiratory tract and completely protected healthy ferrets from infection.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus